Cite
HARVARD Citation
Fagerli, K. et al. (2013). AB0516 Characteristics and treatment response of patients with axial spondyloarthritis (axspa) starting with sulfasalazine (ssz) or tnf-inhibitor (tnfi) as the first dmard.. Annals of the rheumatic diseases. pp. A946-A947. [Online].